From Translation to Market-Entry: Advance Formulation, Clinical Development, & Commercialization of Phage-Based Therapies at the 4th Bacteriophage Therapy Summit 2022.

Returning for its 4th year, the Bacteriophage Therapy Summit remains the only industry-focused forum dedicated to facilitating the discovery, translation & acceleration of bacteriophage research into targeted therapeutics with clinically significant results. View the full event guide here: https://ter.li/ehl7e1

2022 Agenda Overview:

• Navigate clinical trial rationale, distribution effects of formulation on reaching infection sites, lessons learned from compassionate use trials, and the regulatory pathway for commercial development with the hottest insights from our 35+ expert speaker faculty
• Hear from international organizations including the FDA, BiomX, Locus Bioscience, Felix Bioscience, Phagomed, PhagePro, Cytophage, Sciphage and unite with the phage community prioritizing human health and diseas
• Discuss strategies to weaponize phage therapies including lysins, genetic engineered and combination approaches to create new pathways for the treatment of infectious diseases, across 3 days of unparalleled, industry-centered content
• Keep your company’s interest in bacteriophage therapies up-to-date and aligned with the new breakthroughs beyond basic science and establish your pathway to commercialization in 2022 and beyond

See our full speaker faculty, all agenda topics, and our attending audience in our event brochure: https://ter.li/ehl7e1

Join us to develop the next generation of phage therapy products disrupting the medical and healthcare industries for a better tomorrow. Early booking and group discounts are available upon request. Please visit the website for more information on registration fees and discounts. https://ter.li/1szl1y